William Howard Tepp

USPTO Granted Patents = 12 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 75(Granted Patents)

Location History:

Stoughton, WI (US) (2002 - 2018)
Madison, WI (US) (2015 - 2020)
Milwaukee, WI (US) (2022)

Company Filing History:

9 out of 4,131

Wisconsin Alumni Research Foundation

University of California

patents

4. 1 out of 1,187

The Scripps Research Institute

patents

5. 1 out of 183

The Medical College of Wisconsin, Inc.

patents

6. 1 out of 832,912

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11491239 - Modified clostridial neurotoxins as vaccines and conjugate vaccine platforms (2022-11-08),

2. 10751394 - Neurotoxins and uses thereof (2020-08-25),

3. 10688162 - Hybrid neurotoxins and uses thereof (2020-06-23),

4. 10022450 - Regulation of specific spinal neurons regulating pain transmission via chimeric toxins (2018-07-17),

5. 9498521 - Purification, characterization, and use of Clostridium botulinum neurotoxin BoNT/A3 (2016-11-22),

6. 9447405 - Regulation of specific spinal neurons regulating pain transmission via chimeric toxins (2016-09-20),

7. 9217172 - Compositions and methods for toxigenicity testing (2015-12-22),

8. 8940477 - Method of detecting botulinum neurotoxin and antibodies that neutralize botulinum neurotoxin action (2015-01-27),

9. 8440204 - [object Object] (2013-05-14),

10. 7820411 - [object Object] (2010-10-26),

11. 6670322 - Method of targeting pharmaceuticals to motor neurons (2003-12-30),

12. 6444209 - Hybrid botulinal neurotoxins (2002-09-03),

Title: The Innovative Contributions of William Howard Tepp

Introduction

William Howard Tepp is a notable inventor based in Stoughton, WI (US), recognized for his significant contributions to the field of biotechnology. With a total of 12 patents to his name, Tepp has made remarkable advancements, particularly in vaccine development and neurotoxin research.

Latest Patents

Among his latest patents, Tepp has developed "Modified clostridial neurotoxins as vaccines and conjugate vaccine platforms." This patent presents engineered non-catalytic, non-toxic tetanus toxin variants and outlines methods for using these variants as low-dose, protective vaccines that are non-toxic and more potent than their chemically inactivated counterparts. Additionally, he has introduced conjugate vaccine carriers that utilize engineered tetanus toxin variants, aimed at eliciting T-cell dependent immune memory responses to target a broad spectrum of microbial pathogens with a single vaccine. Another significant patent is titled "Neurotoxins and uses thereof," which focuses on botulinum neurotoxins with altered properties and their various applications, including research, screening, and therapeutic uses.

Career Highlights

Tepp has had a distinguished career, working with prominent organizations such as the Wisconsin Alumni Research Foundation and Cellsnap LLC. His work has not only contributed to scientific knowledge but has also paved the way for practical applications in medicine and healthcare.

Collaborations

Throughout his career, Tepp has collaborated with esteemed colleagues, including Eric Arthur Johnson and Sabine Pellett. These partnerships have further enhanced his research and innovation efforts.

Conclusion

William Howard Tepp's innovative work in the field of biotechnology, particularly in vaccine development and neurotoxin research, showcases his dedication to advancing medical science. His contributions continue to have a lasting impact on the industry and public health.

This text is generated by artificial intelligence and may not be accurate.